Article Details

AstraZeneca to Tap Invitae's Ciitizen Patient-Consented Database for Rare Cancer Research

Retrieved on: 2022-10-28 15:30:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to Tap Invitae's Ciitizen Patient-Consented Database for Rare Cancer Research. View article details on HISWAI: https://www.insideprecisionmedicine.com/topics/oncology/immunotherapies/astrazeneca-to-tap-invitaes-ciitizen-patient-consented-database-for-rare-cancer-research/

Excerpt

Medical genetics company Invitae announced on Thursday that it has inked a collaboration with pharma heavyweight AstraZeneca to leverage Invitae's ...

Article found on: www.insideprecisionmedicine.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up